For a detailed, up-to-date understanding of issues and options related to the use of DSNPs as a platform for Medicare-Medicaid integration, the project team conducted five telephone interviews with subject matter experts
Table of Contents What Are GLP1 Therapies and Why They Matter Evidence on GLP1 and Dementia Risk: Current Studies Mechanisms That Might Underlie Brain Effects Clinical Implications for Patients with Diabetes Where Research Is Headed FAQs What Are GLP1 Therapies and Why They Matter GLP1 receptor agonists (GLP1 RAs) are medications used to treat type 2 diabetes and obesity
(no photo available) 96 tests $834 CSB-EL001198HU Acyl-coenzyme A synthetase ACSM3, mitochondrial (ACSM3) ELISA Kit, Human For quantitative detection in human samples
Park J R, Lee H, Kim S I, et al
Alano, C
Compared with GLP-1 RAs, more participants receiving tirzepatide 15 mg discontinued treatment due to adverse events (OR 2.29 [95% CI 1.39, 3.75], I 2 0%), whereas no difference was evident for tirzepatide 5 mg and 10 mg (ESM Table 3)